Literature DB >> 25448306

The kallikrein system in retinal damage/protection.

Tomomi Masuda1, Masamitsu Shimazawa2, Hideaki Hara3.   

Abstract

Kallikrein is a serine protease involved in the kallikrein-kinnin system. Kallikrein is derived from the blood plasma or tissue, and is correlated with aggravation and improvement in eye diseases, such as, glaucoma, diabetic retinopathy, age-related macular degeneration, and ocular ischemic syndrome. The plasma kallikrein stimulates retinal vascular permeability and intraocular hemorrhage. On the other hand, we had reported that the tissue kallikrein normalizes retinal vasopermeability and inhibited retinal neovascularization and retinal ischemic injury. The protective mechanisms of the tissue-derived kallikrein include the cleavage of vascular endothelial growth factor (VEGF), which suggests that the tissue kallikrein could be potentially-effective against any disease involving the VEGF production.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age-related macular degeneration; Bradykinin (PubChem CID: 439201); Diabetic retinopathy; Glaucoma; Kallidin (PubChem CID: 5311111); Kallikrein; Ocular ischemic syndrome; Prostaglandin E2 (PubChem CID: 5280360); Vascular endothelial growth factor

Mesh:

Substances:

Year:  2014        PMID: 25448306     DOI: 10.1016/j.ejphar.2014.10.007

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.

Authors:  Takeshi Kita; Allen C Clermont; Nivetha Murugesan; Qunfang Zhou; Kimihiko Fujisawa; Tatsuro Ishibashi; Lloyd Paul Aiello; Edward P Feener
Journal:  Diabetes       Date:  2015-05-15       Impact factor: 9.461

2.  Plasma Kallikrein Inhibitors for the Treatment of Retinal Vascular Permeability Associated with Diabetic Retinopathy and Diabetic Macular Edema.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2017-07-11       Impact factor: 4.345

3.  Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction: A case report.

Authors:  Kenji Tsuchihashi; Hozumi Shimokawa; Kotoe Takayoshi; Kenta Nio; Tomomi Aikawa; Yuzo Matsushita; Iori Wada; Shuji Arita; Hiroshi Ariyama; Hitoshi Kusaba; Koh-Hei Sonoda; Koichi Akashi; Eishi Baba
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

4.  Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.

Authors:  Yuming Li; Guixue Hou; Haibo Zhou; Yanqun Wang; Hein Min Tun; Airu Zhu; Jingxian Zhao; Fei Xiao; Shanwen Lin; Dongdong Liu; Dunrong Zhou; Lang Mai; Lu Zhang; Zhaoyong Zhang; Lijun Kuang; Jiao Guan; Qiushi Chen; Liyan Wen; Yanjun Zhang; Jianfen Zhuo; Fang Li; Zhen Zhuang; Zhao Chen; Ling Luo; Donglan Liu; Chunke Chen; Mian Gan; Nanshan Zhong; Jincun Zhao; Yan Ren; Yonghao Xu
Journal:  Signal Transduct Target Ther       Date:  2021-04-15

Review 5.  Vitreous Humor Proteome: Targeting Oxidative Stress, Inflammation, and Neurodegeneration in Vitreoretinal Diseases.

Authors:  Fátima Milhano Santos; Joana Mesquita; João Paulo Castro-de-Sousa; Sergio Ciordia; Alberto Paradela; Cândida Teixeira Tomaz
Journal:  Antioxidants (Basel)       Date:  2022-03-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.